MAGED A. AZIZ

Dr. MAGED A. AZIZ

Department of Chemistry, Faculty of Science, Zagazig University, Zagazig 44519, Egypt
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Journal of Saudi Chemical Society
Verified
Journal Article
Open access
MAMostafa M.K. Amer
Mostafa M.K. Amer
MAGED A. AZIZMAGED A. AZIZ
MAGED A. AZIZ
WSWesam Saber Shehab
Wesam Saber Shehab
MAMagda Abdellattif
Magda Abdellattif
SMSamar M. Mouneir
Samar M. Mouneir

Verified
Journal Article
Open access
PDF file
MAGED A. AZIZMAGED A. AZIZ
MAGED A. AZIZ
WSWesam Saber Shehab
Wesam Saber Shehab
Ahmed A. Al-KarmalawyAhmed A. Al-Karmalawy
Ahmed A. Al-Karmalawy
AFAhmed F. El Farargy
Ahmed F. El Farargy
MAMagda Abdellattif
Magda Abdellattif
Novel candidates of 3-(4-(thiophen-2-yl)-pyridin/pyran/pyrimidin/pyrazol-2-yl)-1H-indole derivatives (2–12) were designed by pairing the pyridine/pyrane/pyrimidine/pyrazole heterocycles with indole and thiophene to investigate their potential activities as (2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) inhibitors. The purpose of these derivatives’ modification is to create high-efficiency antioxidants, especially against ABTS, as a result of the efficiency of this set of key heterocycles in the inhibition of ROS. Herein, 2D QSAR modeling was performed to recommend the most promising members for further in vitro investigations. Furthermore, the pharmacological assay for antioxidant activity evaluation of the yielded indole-based heterocycles was tested against ABTS (2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid); by utilizing ascorbic acid as the standard. Candidate 10 showed higher antioxidant activity (IC50 = 28.23 μg/mL) than ascorbic acid itself which achieved (IC50 = 30.03 μg/mL). Moreover, molecular docking studies were performed for the newly designed and synthesized drug candidates to propose their mechanism of action as promising cytochrome c peroxidase inhibitors compared to ascorbic acid as a reference standard. Our findings could be promising in the medicinal chemistry scope for further optimization of the newly designed and synthesized compounds regarding the introduced structure-activity relationship study (SAR) in order to get a superior antioxidant lead compound in the near future.

25 June 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
MAMohamed H. M. AbdEl‐Azim
Mohamed H. M. AbdEl‐Azim
MAGED A. AZIZMAGED A. AZIZ
MAGED A. AZIZ
SMSamar M. Mouneir
Samar M. Mouneir
AEAhmed F. El‐Farargy
Ahmed F. El‐Farargy
WSWesam Saber Shehab
Wesam Saber Shehab

4 November 2019 in Synthetic Communications
Verified
Journal Article
Closed access
WSWesam Saber Shehab
Wesam Saber Shehab
AEAhmed F. El-Farargy
Ahmed F. El-Farargy
AAAbdou O. Abdelhamid
Abdou O. Abdelhamid
MAGED A. AZIZMAGED A. AZIZ
MAGED A. AZIZ
Nanoparticles supply an environmentally friendly procedure for the synthesis of pyrano[2,3-d]pyrimidines by the one-pot three-component condensation reaction of thiobarbituric acid and malononitrile with pyrrol-2-carboxaldehyde. The catalyst could be easily recovered using an external magnet and reused for six cycles with almost consistent activity. A facile synthesis of a new series of cyclic and acyclic nucleosides of pyrano[2,3-d]pyrimidines derivatives was performed. The synthesis of poly heterocyclic compounds starting from pyrano[2,3-d]pyrimidines derivatives was achieved. Structures of the newly synthesized compounds were confirmed on the bases of elemental analyses and spectral data (IR, 1H NMR, 13C NMR, and mass spectra). Compound 6 exhibited the most potent biological activity.

25 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
WSWesam Saber Shehab
Wesam Saber Shehab
MAGED A. AZIZMAGED A. AZIZ
MAGED A. AZIZ
NENourhan Kh. R. Elhoseni
Nourhan Kh. R. Elhoseni
MAMohamed G. Assy
Mohamed G. Assy
MAMagda Abdellattif
Magda Abdellattif
EHEman O. Hamed
Eman O. Hamed
On our way to discovering and developing compounds that have an antioxidant impact compared to ascorbic acid and other biological activities, we designed, synthesized, and evaluated a new series of heterocyclic moieties drugs (1–11) as antioxidants and antimicrobial agents. As starting moieties, these new candidates were derived from two promising heterocyclic compounds, imidazoldin-4-one and thiazol-4-one. Firstly, diphenylimidazol 1 was obtained because of the cyclo condensation one-pot ternary reaction of urea, aniline, and chloroacetic acid under thermal conditions. Out of this starting compound, we could design and create new vital rings such as purine and triazine as in compounds 5 and 6, respectively. Secondly, the start thiazole derivative 7 was obtained from the intermolecular cyclization of thiourea, chloroacetic acid, p-nitobezaldehyde in the presence of sodium acetate. We synthesized various derivatives from this second starting compound 7 by being subjected to different reagents such as aniline, phenylenediamine, phenylhydrazine, and barbituric acid to yield 8, 9, 10, and 11, respectively. Using ascorbic acid as the standard compound, the pharmacological testing for antioxidant activity assessment of the produced derivatives was evaluated against ABTS (2,20-azinobis (3-ethylbenzothiazoline-6-sulfonic acid). Candidate 6 exhibited the best activity as an antioxidant agent compared to ascorbic acid as a reference compound. Moreover, all compounds were evaluated as antimicrobial agents against a series of bacteria and fungi. Among all synthesized compounds, compound 6 achieved high efficiency against two types of fungi and four kinds of bacteria, as Clotrimazole and Ampicillin were used as the reference agents, respectively. All chemical structures of the novel synthesized candidates were unequivocally elucidated and confirmed utilizing spectroscopical and elemental investigations.